Scribe Therapeutics Inc. Common Stock SCTX
$15.70
+1.42%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-09-02 | View → |
| 8-K | 8-K | 2026-09-02 | View → |
| 4 | Insider transaction | 2026-07-29 | View → |
| 4 | Insider transaction | 2026-07-29 | View → |
| 4 | Insider transaction | 2026-07-29 | View → |
| 4 | Insider transaction | 2026-07-29 | View → |
| 4 | Insider transaction | 2026-07-28 | View → |
| 4 | Insider transaction | 2026-07-28 | View → |
| 4 | Insider transaction | 2026-07-27 | View → |
| 4 | Insider transaction | 2026-07-27 | View → |
| 4 | Insider transaction | 2026-07-27 | View → |
| 4 | Insider transaction | 2026-07-27 | View → |
| 4 | Insider transaction | 2026-07-27 | View → |
| 4 | Insider transaction | 2026-07-27 | View → |
| 4 | Insider transaction | 2026-07-27 | View → |
| 8-K | 8-K | 2026-07-27 | View → |
| S-1 | S-1 | 2026-07-02 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $15.70
- Market Cap
- $297.23 million
- 52-Week Range
- $13.50 – $39.60
- Average Volume
- 451K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.